Quarterly report pursuant to Section 13 or 15(d)

Stock Warrants (Details Narrative)

v3.7.0.1
Stock Warrants (Details Narrative)
 3 Months Ended
Mar. 31, 2017
$ / shares
shares
Class of Warrant or Right [Line Items]  
Warrants outstanding (shares) | shares 16,900,000
Common Stock [Member] | Macrophage Therapeutics Inc [Member]  
Class of Warrant or Right [Line Items]  
Outstanding number of warrant to be converted to common stock | shares 300
Minimum [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 0.01
Warrant, Outstanding Term 1 year
Maximum [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 3.04
Warrant, Outstanding Term 18 years
Weighted Average [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 1.19